Updated:
Octave Life Sciences
Octave Life Sciences Pvt. Ltd. was established in 2018 with headquarters in Mumbai, India.
Octave Life Sciences
Octave Life Sciences Pvt. Ltd. was established in 2018 with headquarters in Mumbai, India. The firm focuses on marketing pharmaceutical products that meet global quality standards and has built a portfolio of over 15 products across multiple dosage forms including tablets, capsules, injections, syrups, and ointments. The company markets products for both the Indian domestic market and export markets. Its featured brands include Pencifast, Immunfast, Pidimol, Cefobid, and Azimist among others. Octave’s product range spans anti-infectives, analgesics, nutritional supplements, and dermatological preparations. The firm emphasizes quality control and a strong marketing team to drive growth. Octave Life Sciences employs a sales-driven model with a focus on rapid market expansion. The company maintains a website at octavelifesciences.com and a contact number +91-98217 97976. No additional offices, team sizes, or deal activity have been publicly disclosed. The firm's public presence is limited to its corporate website with no LinkedIn or other social media profiles found. The company operates as a traditional pharmaceutical marketer rather than a family office or investment firm. Its structural differentiator is its narrow focus on generic pharmaceutical products with a growth-oriented export strategy, lacking the multi-asset mandate typical of family offices.
General information
Firm type
other
Year founded
2018
AUM
Undisclosed
Location
Region
Asia
Country
India
City
Mumbai
Corporate office
Mumbai, India
Sector focus
Frequently asked questions
Is Octave Life Sciences a family office or investment firm?
No. Octave Life Sciences is a pharmaceutical marketing company, not a family office or investment manager. It markets generic drug products such as tablets, capsules, injections, syrups, and ointments for the Indian domestic and export markets (per the firm's website). The firm's structure and mandate are commercial rather than allocative.
Who owns Octave Life Sciences?
Ownership of Octave Life Sciences is not publicly disclosed. The firm's website lists no principals or shareholders. Without a public register or credible third-party source, ownership information remains unavailable.
Does Octave Life Sciences invest in other companies?
There is no public evidence that Octave Life Sciences engages in venture capital, private equity, or any form of external investment. The company's website describes it as a marketer of pharmaceutical products, not an investment vehicle.
What products does Octave Life Sciences sell?
Octave Life Sciences markets over 15 pharmaceutical products in forms including tablets (Pencifast-625, Immunfast, Pidimol-650), capsules (Ocikill, Itave-200, Ostave), injections (Pidimol AQ, Panrium-40, Tazodac, Pidisunate), syrups (Hepamate, Silenser-D, Fast-D3), and an ointment (Dermisytic). Many are generic versions of antibiotics, analgesics, and nutritional supplements (per the firm's website).
Where does Octave Life Sciences operate geographically?
The firm is headquartered in Mumbai, India, and markets products domestically as well as to export markets. Specific export countries are not named on the company's website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: